General Information of Drug (ID: DMZDA25)

Drug Name
ASP9853
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
TTD ID
D0C1TR

References

1 Clinical pipeline report, company report or official report of Astellas Pharma.